Picchio, Camila A. http://orcid.org/0000-0002-0321-662X
Nomah, Daniel K.
Rando-Segura, Ariadna
Buti, Maria
Lens, Sabela
Forns, Xavier
Tajes, Sergio Rodriguez
Fernández, Emma
Pamplona Portero, Javier
Nuñez, Carmen López
van Selm, Lena
MacKinnon, Marina http://orcid.org/0009-0005-4818-1722
Araujo, Silvia G.
Martró, Elisa
Rodríguez-Frías, Francisco
Lazarus, Jeffrey V. http://orcid.org/0000-0001-9618-2299
Article History
Received: 6 June 2023
Accepted: 30 November 2023
First Online: 14 December 2023
Competing interests
: The authors declare the following competing interests: C.A.P., D.K.N., A.R.S., E.F., Lv.S., M.M., S.G.A. and F.R.F. have no competing interests to report. S.L. has received research grants from Gilead Sciences and speaker and travel fees from Gilead and Abbvie; M.B. has acted as an advisor for Gilead Sciences, GSK, Abbvie, and Roche Diagnostics; X.F. has acted as an advisor for Gilead Sciences and Abbvie; S.R.T. reports speaker fees from Gilead Sciences and Abbvie, outside the submitted work; J.P.P. has received speaker fees from Gilead Sciences and Abbvie; C.L.N. has received speaker fees from Gilead Sciences and Abbvie; E.M. has received lecture fees and research grants from Abbott GmbH & Co. K.G., Gilead Sciences, Cepheid and Abbvie, outside of the submitted work; J.V.L. acknowledges grants and speaker fees from AbbVie, Gilead Sciences, MSD, and Roche Diagnostics to his institution, speaker fees from Echosens, Janssen, Novo Nordisk, and ViiV, and consulting fees from Novavax, outside of the submitted work.